pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,879 catalysts · 4,876 phase readout · 2,366 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 28 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: drug expiry×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,366
  • earnings286
  • pdufa275
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Infectious Disease3

    Date TBD

    50
    ›RECRUITINGphase readoutNCT05565118: Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression

    Sponsor: Case Comprehensive Cancer Center. Phase: PHASE1. Conditions: High Grade Glioma, Glioblastoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02489318: A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC

    Sponsor: Aragon Pharmaceuticals, Inc.. Phase: PHASE3. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07266090: A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)

    Sponsor: Viatris Pharmaceuticals Co., Ltd.. Phase: PHASE2. Conditions: SLE - Systemic Lupus Erythematosus

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03875690: Benefit of a Flash Dose of Corticosteroids in Digestive Surgical Oncology: a Randomized, Double Blind, Placebo-controlled Trial

    Sponsor: Centre Hospitalier Universitaire Dijon. Phase: PHASE3. Conditions: Elective Surgery for Any Digestive Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04879290: Comparison of Two FiO2 (1 or 0.5) for Tracheal Extubation in Post-anesthesia Care Unit

    Sponsor: University Hospital, Caen. Phase: NA. Conditions: Anesthesia, Atelectasis, Postoperative Complications, Hypoxemia, Hyperoxia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05085210: Improving Visual Field Deficits With Noninvasive Brain Stimulation

    Sponsor: Beth Israel Deaconess Medical Center. Phase: NA. Conditions: Visual Field Defect, Peripheral, Stroke, Visual Impairment, Hemianopsia, Quadrantanopia, Cortical Blindness, Visual Field Defect Homonymous Bilateral, Occipital Lobe Infarct, Visual Fields Hemianopsia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06251310: SW-682 in Advanced Solid Tumors

    Sponsor: SpringWorks Therapeutics, Inc.. Phase: PHASE1. Conditions: Advanced Solid Tumor, Mesothelioma, Malignant

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06633913: Concurrent TMS-fMRI

    Sponsor: Jing Jiang. Phase: NA. Conditions: Healthy Control, Depression

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06368323: Effect of Community Choir Singing in People With Chronic Post-stroke Aphasia

    Sponsor: University of Ottawa. Phase: NA. Conditions: Aphasia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03391323: Medacta GMK Sphere® vs. Medacta GMK PS Post-Market Outcomes Study

    Sponsor: David F. Scott, MD. Phase: NA. Conditions: Osteoarthritis, Osteoarthritis, Knee, Joint Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06795659: Combining Esketamine and Prolonged Exposure Treatment for PTSD (Post Traumatic Stress Disorder)

    Sponsor: The University of Texas Health Science Center at San Antonio. Phase: PHASE1. Conditions: Post Traumatic Stress Disorder PTSD

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05051059: Assessment of the Functional Outcome and Quality of Life in Sarcoma Patients

    Sponsor: Universitaire Ziekenhuizen KU Leuven. Phase: NA. Conditions: Soft Tissue Sarcoma, Bone Sarcoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02400359: Lorcaserin in Obesity: Identification of CNS Targets Using fMRI

    Sponsor: Beth Israel Deaconess Medical Center. Phase: PHASE4. Conditions: Obesity, Weight Loss

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05758480: Characterization of the Immunometabolic Signature in Long COVID-19.

    Sponsor: University Hospital, Angers. Phase: NA. Conditions: Long COVID

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07402096: Effect of a Mindfulness-Based Stress Reduction Program on Hot Flashes and Sleep Quality in Menopausal Women: A Randomized Controlled Trial

    Sponsor: Inonu University. Phase: NA. Conditions: Menopause, Hot Flashes, Sleep Wake Disorders

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07156162: Effectiveness of Taste vs. Health-Based Messaging to Improve Diet Quality

    Sponsor: Penn State University. Phase: NA. Conditions: Behavior, Health

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07539662: Unrelated Umbilical Cord Blood Transplantation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

    Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: NA. Conditions: ALS (Amyotrophic Lateral Sclerosis)

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT02886546: Utility of Dynamic Variables Measured by Calibrated Pulse Contour Analysis of Oesophageal Doppler Monitor for Predicting Fluid Responsiveness During Robot-Assisted Laparoscopic Prostatectomy

    Sponsor: Hallym University Kangnam Sacred Heart Hospital. Phase: NA. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07444346: Intravascular Imaging-Guided Intravascular Lithotripsy for Severe Coronary Calcified Lesions.

    Sponsor: The First Affiliated Hospital with Nanjing Medical University. Phase: . Conditions: Coronary Artery Calcification, Coronary Artery Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07116746: Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients

    Sponsor: Arthrosi Therapeutics. Phase: PHASE2. Conditions: Gout, Gouty Arthritis, Hyperuricemia, Gout Chronic, Refractory Gout, Uncontrolled Gout, Tophaceous Gout

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07479303: Vitamin D Status in Young Medical Residents

    Sponsor: Maimónides Biomedical Research Institute of Córdoba. Phase: . Conditions: Vitamin D Deficiency

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06335303: A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

    Sponsor: Boehringer Ingelheim. Phase: PHASE2. Conditions: Idiopathic Pulmonary Fibrosis

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05268003: A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Acute Lymphoblastic Leukemia, Leukemia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07455227: ERCP Management in Mild Gallstone-Induced Pancreatitis Patients Declining Subsequent Cholecystectomy : a Randomized Control Trial.

    Sponsor: Fu Jen Catholic University Hospital. Phase: NA. Conditions: Pancreatitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03586427: Zelquistinel in the Treatment of Major Depressive Disorder

    Sponsor: Syndeio Biosciences, Inc. Phase: PHASE2. Conditions: Depressive Disorder, Major

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT01453127: DaTSCAN Imaging in Aging and Neurodegenerative Disease

    Sponsor: Mayo Clinic. Phase: PHASE4. Conditions: Dementia, Parkinsonism, Mild Cognitive Impairment, REM Sleep Behavior Disorder

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04318327: BCMA-directed CAR-T Cell Therapy in Adult Patients With Multiple Myeloma

    Sponsor: Novartis Pharmaceuticals. Phase: PHASE1. Conditions: Multiple Myeloma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04228627: Ferritin Screening And IRon Treatment for Maternal Anemia and FGR Prevention Trial

    Sponsor: Services Institute of Medical Sciences, Pakistan. Phase: PHASE4. Conditions: Iron Deficiency (Without Anemia), Pregnancy Related

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06928727: Ocular Characteristics in Patients With Craniosynostosis

    Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: . Conditions: Craniosynostosis, Strabismus, Intracranial Hypertension, Amblyopia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07398742: Incidence and Microbial Profiles of Periprosthetic Joint Infection After Total Knee Arthroplasty in Obese vs Non-Obese Patients

    Sponsor: Bispebjerg Hospital. Phase: . Conditions: Knee Arthropathy, PJI

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06990750: Single Port Insufflation RCT

    Sponsor: University of Chicago. Phase: NA. Conditions: Postoperative Pain Score

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06891950: Butantan-DV Vaccine in Elderly Populations (DEN-04-IB)

    Sponsor: Butantan Institute. Phase: PHASE3. Conditions: Dengue

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07206550: The Role of Framing and Choice Architecture in Patients' Reactions and EHR Error Discovery and Reporting

    Sponsor: The University of Texas at Dallas. Phase: NA. Conditions: Electronic Health Records

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07251491: Psilocybin to Treat Depression in Spinal Cord Injury

    Sponsor: James J. Peters Veterans Affairs Medical Center. Phase: PHASE1. Conditions: Spinal Cord Injury, Depression - Major Depressive Disorder, Veteran

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07491718: Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Cardiomyopathy

    Sponsor: University of Edinburgh. Phase: NA. Conditions: Takotsubo Cardiomyopathy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07359118: Assessment of Healthcare Professionals' Knowledge and Attitudes Toward Patient-Controlled Analgesia

    Sponsor: Kutahya Health Sciences University. Phase: NA. Conditions: Postoperative Pain Management

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07496190: Becotatug Vedotin for LA-NPC With a Suboptimal Response to Induction Chemotherapy Combined With Immunotherapy

    Sponsor: Sun Yat-sen University. Phase: PHASE2. Conditions: Nasopharyngeal Cancinoma (NPC)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05210413: Spartalizumab and Low-dose PAzopanib in Refractory or Relapsed Solid TumOrs of Pediatric and Adults

    Sponsor: University Hospital, Bordeaux. Phase: PHASE1. Conditions: Refractory or Recurrent Solid Tumor

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06727513: A Two-Operator Technique for GlideScope-Assisted Endotracheal Intubation

    Sponsor: American University of Beirut Medical Center. Phase: NA. Conditions: Intubation; Difficult or Failed, Intubation Complication, Airway Trauma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07039760: Asciminib With or Without Sildenafil for Brain Tumors

    Sponsor: Washington University School of Medicine. Phase: EARLY_PHASE1. Conditions: Brain Tumor

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07148024: Cuff Pressure and Airway Edema in CABG With CPB

    Sponsor: Engin Çetin. Phase: NA. Conditions: Airway Ultrasound, Airway Edema, Endotracheal Tube

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04242823: Primary HPV-based Cervical Cancer Screening Algorithms in Botswana

    Sponsor: Beth Israel Deaconess Medical Center. Phase: NA. Conditions: Cervical Cancer, Prevention

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT00001823: Evaluation for NCI Surgery Branch Clinical Research Protocols

    Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Synovial Cell Cancer, Melanoma, Colorectal Cancer, Lung Cancer, Bladder Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05064280: Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Brain Metastases, Tumor

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04982796: Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder

    Sponsor: Portland VA Research Foundation, Inc. Phase: PHASE1. Conditions: Amphetamine-Related Disorders

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05609188: Black Economic Equity Movement

    Sponsor: University of California, San Francisco. Phase: NA. Conditions: Mental Health Wellness 1, Health Care Utilization, Financial Hardship, Education, Professional

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07214688: Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies

    Sponsor: Hackensack Meridian Health. Phase: PHASE2. Conditions: Allogeneic Stem Cell Transplant Recipient

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07294703: Factors Associated With Breast Cancer Risks and Outcomes

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Breast Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07264361: Evaluation of the Safety and Efficacy of the D.D.C Dual-control Technology Spectacle Lenses in Delaying the Progression of Myopia: a Randomized Controlled Trial

    Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University. Phase: NA. Conditions: Myopia, Progressive

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04943861: Human Immunodeficiency Virus (HIV) Food Insecurities

    Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Food Insecurities, Cardiometabolic Comorbidities, HIV, PreDiabetes, Type 2 Diabetes Mellitus (T2DM)

    full page →ctgov ↗
    ← prev
    page 14 of 98
    next →